Elsevier: Preprints With The Lancet Launches on SSRN

Food and Healthcare Press Releases Friday June 29, 2018 18:23
LONDON--29 Jun--PRNewswire/InfoQuest

SSRN , Elsevier's world leading preprint server and early stage research platform, has today announced the launch of 'Preprints with The Lancet' - a new preprint series for sharing early stage health and medical research.

(Logo: https://mma.prnewswire.com/media/712610/Preprints_with_The_Lancet_Logo.jpg )
The collaboration brings together SSRN with   The Lancet as part of a six-month pilot to assess whether the health and medical community are ready for this form of early research sharing.

Preprints are research papers that are at the submission stage or can be described as on-going research. By sharing online, authors widen the opportunity for receiving comments on their work by other researchers with the goal of an improved final peer-reviewed publication and for exchange of research areas with the future potential for collaboration. Preprints are primarily intended for research use; they have not been through the important steps of peer review and experienced editorial scrutiny and guidance that is part of the publishing process. All papers on 'Preprints with The Lancet' will be free to upload and download.

Dr. Richard Horton, Editor-In-Chief of The Lancet, said: "Preprints have a long history in physics, mathematics, and, more recently, social sciences and biological fields, but medicine and health have been lagging behind. Our preprint pilot will be a first attempt to establish whether there is an appetite in the medical research community for obtaining feedback on ongoing or submitted research in the form of preprints, and whether such postings are a useful step in the research and publishing process."

Authors of all research papers submitted to any Lancet family journal, will be asked at submission whether they would like their paper to be posted - as a preprint, an opt-in that all co-authors must agree to. Authors can also submit their papers through SSRN directly.

Submitted papers will be subject to SSRN's usual checks to ensure that the paper is part of the scholarly discourse, in a subject area covered by one or more of SSRN's networks. A Lancet editor will then check the paper and ensure the authors have provided a statement about the funding of the study; a summarized declaration of interests for all authors; a statement on ethics approval or why the research was exempted; and if the research is a randomized trial, confirmation that it has been prospectively registered along with the trial registration number. Once a final version of a preprint paper is peer-reviewed and published and becomes part of the scientific evidence as the version of record, authors are encouraged to link to the preprint of the published paper.

Gregg Gordon, Managing Director of SSRN, added: "It's fantastic The Lancet has decided to embrace preprints and launch this new series. We have over 20 years' experience helping researchers from across the world, and from all scientific disciplines, collaborate and share their early stage research. With the new Sneak Peek series from Cell Press recently launched on SSRN, we have two of the world's leading journals from Elsevier working in partnership with us."

Note for editors
Interviews with Gregg Gordon, Managing Director of SSRN, are available on request.
For more information about Preprints with The Lancet please see: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31125-5/fulltext and https://www.thelancet.com/preprints .
About SSRN

SSRN is a worldwide collaborative of over 350,000 authors and more than 2.2 million users that is devoted to the rapid worldwide dissemination of research. Founded in 1994, it is now composed of a number of specialized research networks. Each of SSRN's networks encourages the early distribution of research results by reviewing and distributing submitted abstracts and full text papers from scholars around the world. SSRN encourages readers to communicate directly with other subscribers and authors concerning their own and other's research. Through email abstract eJournals, SSRN currently reaches over 400,000 people in approximately 140 different countries.

About Elsevier

Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect , Scopus , SciVal ,   ClinicalKey and Sherpath . Elsevier publishes over 2,500 digitized journals, including   The Lancet and Cell , 38,000 e-book titles and many iconic reference works, including Gray's Anatomy . Elsevier is part of RELX Group , a global provider of information and analytics for professionals and business customers across industries. http://www.elsevier.com

Media contact
David Tucker, Global Communications
Elsevier
+44-7920-536-160
d.tucker@elsevier.com
Source: Elsevier

Latest Press Release

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

TIENS Group Launches Global Expansion Into New Retail

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features...

Related Topics